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Abstract. A series of protease inhibitors were tested 
on the motility of human, rat, bull, and rabbit de- 
membranated reactivated spermatozoa. Some inhibi- 
tors, including aprotinin, boc-gln-leu-lys-H, and D- 
phe-pro-arg-H, could inhibit motility as well as pre- 
vent initiation of motility. In general, with the excep- 
tion of aprotinin, protease inhibitors were more po- 
tenl in preventing the initiation of movement than in 
blocking motility of demembranated spermatozoa. 
Protease substrates could also block sperm motility. 
Of the substrates tested only those with arg or lys ester 
bonds were active. The inhibition of motility by pro- 
tease substrates was reversible, as once spermatozoa 
hydrolyzed the added exogenous protease substrates, 
motility reappeared. The importance of ester bond in 
the inhibitory action of protease substrates was con- 
firmed by experiments that showed the lack of effect 
of pre-hydrolyzed protease substrates. 
The results suggest that a serine prmease with lys 
and arg ester bond specificity is involved in the con- 
trol of sperm motility. The fact that protease sub- 
strates also block motility of intact spermatozoa fur- 
ther emphasizes the physiological relevance of this 
new regulatory system. 
p 
ROTEASES fulfill two main functions: protein degrada- 
tion as m protein turnover and protein limited degra- 
dation as in the activation or modulation of protein 
action. The importance of this second function is becoming 
more and more recognized. Several  peptide hormones exist 
in a precursor form, and the action of specific proteases, often 
localized in  the  same  storage organelles, yields active hor- 
mones (6). Proteases have also been shown to be involved in 
receptor-mediated events such as in the modulation of the ~- 
adrenergic-receptor adenylate cyclase system (I 8) and in in- 
sulin action (1). 
Acrosin, the most extensively studied protease associated 
with spermatozoa, is a trypsin-like protease involved in fertil- 
ization (21 ). Acrosin has been reported both in the acrosomal 
sac and on the inner acrosomal membrane where it exists in 
the form of proacrosin ( 14, 21). A different trypsin-like pro- 
tease  has  also  been  isolated  from  bull  spermatozoa.  This 
enzyme can activate adenylate cyclase from rat brain (10) and 
human plalelels (11). Kallikreins have been reported to affect 
sperm  motility by generating kinins, which presumably act 
on  motility (17).  However, no  protease  has  been  directly 
implicated in sperm motility. 
Recently, we have reported that aprotinin, a protease inhib- 
itor,  blocked  the  motility  of  demembranated  reactivated 
mammalian spermatozoa (2, 3) without significantly affecting 
the force-generating dynein ATPase (8). In the present study, 
we investigated in more detail the possible  involvement of a 
protease in sperm  motility. We now report that a  series  of 
protease inhibitors as well as a  series  of protease substrates 
with lys or arg ester bonds inhibit the motility of  both demem- 
branated reactivated and  intact spermatozoa. These results 
suggest that a serine protease modulates sperm motility. 
Materials and Methods 
Materials 
The protease  mhibitors  soybean  trypsin inhihitor (STI)?  tima  bean trypsin 
inhibitor  (LBTI),  leupeptin  (N-acetyl-leu-leu-arglnal),  antioapain  ([(s)-l-car- 
boxy-2-ohenylethyl]-carbamoyl-arg-val-arginal),  N-<,-p-tosyl-lysine  chloro- 
methyl  ketone  (TLCK),  /-1-tosylamide-2-phenylethyl  chloromethyl  ketone 
(TPCK),  diisopropyl  fluorophosphate  (DFP),  benzamidin; the protease  sub- 
strates benzoyl-phe-val-arg-p-nitroanilide,  N-a-benzoyl-arg ethyl ester, (BAEE), 
succinyl-phe-p-nitroanilide,  N-benzoyl-tyr-p-nitroanilide;  and Ficoll, Triton X- 
100,  trypsin (2×  crystallized),  cAMP,  bovine  serum  albumin  (BSA) were 
purchased  from Sigma Chemical  Co.  (St.  Louis,  MO),  2-[N-hydroxycarbox- 
amido]-4-methylpentanoyl-arg-gly  amide)  (Zincov  inhibitor),  D-phe-pro-arg 
chloromethyl  ketone (PPACK),  N-c~-benzyloxycarbonyl-lys thiobenzyl  ester 
(BLT), and benzoyl-DL-arg-p-nitroanilide (BAPNA), were from  Calbiochem- 
Behnng Corp.  (La Jolla,  CA). Tosyl-gly-pro-arg-p-nitroanilide  acetate  (Chro- 
mozym  TH).  carbobenzoxy-val-gly-arg-p-nitrnanilide  aeelale  (Chromozym 
TRY), S-benzyl-cys-p-nitroanilide,  vanadium-free  ATP (disodium  salt), phen- 
yImethylsuIfonyi fluod.de, and aprotinin were obtained from Boe~riuger-Mar~n- 
helm Diagnostics, Inc. (Montreal).  Boc-gln-leu-lysinal and  o-phe-pro-arginal 
were  given  generously  by  Dr.  Gabor  B.  Makara,  Institute  of Experimental 
Medicine.  Hungarian  Academy of Sciences, Budapest,  Hungary.  Percoll was 
J  Abbreviations  usedin thispaper: BAPNA, benzoyI-DL-arg-/;-nitroanilide: BLT, 
N-ce-benzyloxycarbonyI-Iys thiobenzy[  ester,  Chromozym TH,  tosyi-gly-pro- 
arg-p-nitroanilide acetate; DFP, diisopropyl fluorophosphate;  DMSO, dimethyl 
sulfoxide, DTT, dithiothreitol-  HBS, Hepes balanced  saline, LBTI, lima bean 
trypsin  inhibitor;  STI,  soybean  trypsin  inhibitor:  TLCK,  N-a-p-tosyl-lysine 
chloromethyl  ketone;  TPCK.  /-1-tosylamide-2-phenylethyl  chloromethyl  ke- 
tone, 
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at least of reagent grade. Protease inhibitors  or substrates were solubilized in 
water  or dimethyl  sulfoxide  (DMSO)  or  in  a  1:1  mixture  of DMSO  and 
reactivation medium (described below). DMSO concentrations  never exceeded 
1% in the final assay conditions. At this concentration  DMSO has no effect on 
sperm motility. 
Reactivation of Demembranated Spermatozoa 
Collection and preparation  of ejaculated rabbit and of bull cauda epididymal 
spermatozoa  was done  as previously described (3, 4).  Rat spermatozoa  were 
obtained from cauda epididymides by mincing tissues in Gey's + BSA medium 
(2.5 ml/cauda).  Sperm suspensions were filtered through cheesecloth to remove 
epididymal fragments and centrifuged at 200 g for 5 min at room temperature. 
The supernatant was discarded, the very soft pellet was resuspended in demem- 
branation  medium (0.1% Triton X-100, 200 mM sucrose, 25 mM potassium 
glutamate,  1 mM dithiothreitol  [DTT]  and 35  mM Tris-HCl, pH 8; 2.5  ml/ 
original cauda) (2, 15), and immediately overlaid on 3.5% Ficoll in reactivation 
medium (4 ml/original  cauda)devoid of Triton  X-100. After a 5-min centrif- 
ugation  at  300 g the soft pellet of spermatozoa  was adjusted  to the  desired 
concentration  with reactivation medium devoid of Triton  X-100. Assays were 
run in the same medium. 
Human semen  collected by masturbation  was obtained  from  volunteers. 
Only samples with more than 50% of progressive motility were processed for 
the various studies. The semen was allowed to liquify and was filtered through 
cheesecloth to remove any residual coagulum.  Percoll density gradients were 
prepared as described by Lessley and Garner (12) with the following modifica- 
tions:  (a) volumes  used were smaller, 0.5  ml  of 95%  Percoll buffered  with 
Hepes balanced saline (HBS) +  BSA (10 mM Hepes,  130 mM NaCI, 4 mM 
KCI, l mM CaCI2, 0.5 mM MgCI2, 14 mM fructose, 1 mg/ml BSA adjusted to 
pH 8.0) was placed into a  15-ml conical sterile tube and overlayed with an 8- 
ml continuous linear gradient: (b) the gradient ranged from  15 to 65% Percoll 
buffered with HBS +  BSA, since it permitted  better  recoveries than the  15- 
75%  previously  used.  Filtered  semen  samples  were overlaid  on the  Percoll 
gradients  and centrifuged at  room temperature  for 45  min at  1,300 g. Sper- 
matozoa  were manually  recovered from the  65-95%  Percoll interface to the 
bottom of the tube. 
Rabbit, bull, and human spermatozoa were demembranated  and reactivated 
in the medium described above. Movement was reinitiated by the addition  of 
0.5  mM Mg.ATP (final concentration,  made of 0.5  mM ATP and 0.5  mM 
MgSO0. cAMP (50 u.M, final concentration) was added to the demembranation 
medium when bull spermatozoa were used since it increased the beat frequency 
and the  percentage of motile  reactivated  spermatozoa  from the  bull  cauda 
epididymis (5,  13). cAMP was not used with spermatozoa  from other species 
since it did not significantly improve the reactivation (5; unpublished results). 
Substances to be tested were added either to already reactivated spermatozoa 
(Mg-ATP present in the medium before the addition  of the test substance) or 
to  spermatozoa  in  demembranation  medium before  the  Mg.ATP-induced 
initiation of movement. Sperm motility was evaluated with an inverted micro- 
scope for the proportion of motile spermatozoa and the duration of  reactivation 
(from the time Mg.ATP was added to the time at which 99% of spermatozoa 
stopped moving). 
Experiments were done at room temperature (20"C) unless indicated. 
Assay Conditions for Intact Spermatozoa 
The effects of various substances that  affected reactivated spermatozoa  were 
also studied on intact spermatozoa  incubated in Gey's + BSA or HBS + BSA 
buffers. Percentage and duration  of motility were criteria to evaluate the effects 
of these substances. 
Results 
Effects of  Protease Inhibitors on the Reactivation of 
Mammalian Spermatozoa 
In  the  first series  of experiments, protease inhibitors were 
added to demembranated reactivated spermatozoa (Mg.ATP 
added before the addition of the inhibitor) from rabbits, rats, 
bulls,  and humans (Table I). Of the three macromolecular 
compounds (Group A) tested, only aprotinin could inhibit 
sperm motility at concentrations ranging from 0.5 to 2.6 uM 
for the four species tested. The inhibitory effect of aprotinin 
was  not always  permanent.  At concentrations of aprotinin 
slightly above (5-10%) that required to inhibit motility, the 
movement, after being arrested, usually reinitiated by itself 
after a delay of ~5 min for bull spermatozoa and of 1-2 h for 
rat spermatozoa. This motility lasted at least as long as in the 
Table I. Concentrations of  Protease Inhibitors Needed to Block the Motility of  Demembranated Reactivated Spermatozoa* 
Inhibitory concentrations  (~.M) 
Protease inhibitors  Rabbit  Rat  Bull  Human 
Group A 
STI  >>50  >>50  >>50  >>50 
LBTI  >> 100  >> 100  >> 120 
Aprotinin  0.5  1.3  0.9  2.6 
Group B 
Leupeptin  >>200  >> 1,300  >> 1,200  >> 1,200 
Antipapain  >> 1,000  >> 1,200  >> 1,200 
Boc-gln-leu-lys-H  45  109  79 
D-phe-pro-arg-H  310  215  610 
Group C 
TPCK  >>1,300 
TLCK  >>2,250 
PPACK  )  >> 1,300 
Group D 
Zincov inhibitor  §  >>1,300 
Benzamidin  >>28,000 
DFP  >>90,000 
2,000  2,250 
>>20,600  >> 10,000 
* Sperm were demembranated  and reactivated with 0.5 mM Mg.ATP.  The concentration  of protease inhibitors needed to block completely and instantaneously 
sperm motility was then determined.  Each value represents the mean of at least three different experiments. The symbol >> indicates that the concentration  tested 
had no inhibitory action on sperm motility and that no inhibitory action could be expected near this level. 
) D-phe-pro-arg chloromethyl ketone. 
) 2-(N-hydroxycarboxamido)-4-methylpentanoyl-arg-gly amide. 
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aprotinin, that is 15-20 rain for bull spermatozoa and 3-4 h 
for rat spermatozoa, However, at higher concentrations, the 
inhibition was permanent within the time frame mentioned 
above. 
Two of the four tripeptides with a terminal aldehyde (arg- 
H or lys-H) tested (Group B) inhibited the motility of reacti- 
vated spermatozoa (Table I). Depending on the species inves- 
tigated, boc-gln-leu-lys-H was 2-7.7 times more potent than 
D-phe-pro-arg-H. TLCK, one of the three chloromethyl ke- 
tone tested (Group C), could also block the motility but at 
very high concentrations. Benzamidin and DFP (Group D), 
two potent protease inhibitors,  had no effect on motility at 
concentrations as high as 28 and 90 mM, respectively, even 
after 10 min of contact with spermatozoa. 
In  the  second  series of experiments,  protease  inhibitors 
were added to demembranated spermatozoa before the addi- 
tion of Mg. ATP to test the effect of these substances on the 
initiation of motility (Table II). Under these conditions sper- 
matozoa were generally more sensitive to the effect ofprotease 
inhibitors. STI at 3.7 uM prevented the reactivation of  human 
spermatozoa but had no effect on initiation of motility in the 
three other species investigated. Aprotinin, at concentrations 
very similar to those used to inhibit the motility of already 
reactivated  spermatozoa (Table  I),  could  also  prevent  the 
reactivation of spermatozoa in all four species (Table II). The 
inhibitory potency of tripeptides with terminal aldehyde was 
much  higher when  added  to demembranated spermatozoa 
before the addition  of Mg-ATP than after the initiation  of 
motility. Leupeptin could prevent the motility of rabbit and 
human sperm, whereas boc-gln-leu-lys-H and D-phe-pro-arg- 
H  were  up to  10-fold  more potent.  TLCK was also  more 
potent  in  preventing  sperm  reactivation  than  in  blocking 
already reactivated sperm. These data suggested that a  pro- 
tease was possibly involved in sperm motility. 
Effects of  Protease Substrates on the Reactivation of 
Mammalian Spermatozoa 
To investigate the type of protease that might be involved in 
sperm motility, various protease substrates were tested on the 
motility  of rabbit,  rat,  bull,  and  human  demembranated 
spermatozoa (Table III). Substrates with lysine ester bond (A, 
Table III) or arginine ester bond (B-F) could completely and 
instantaneously (within  5-10 s) inhibit motility. Other sub- 
strates (G-I)  with phenylalanine, tyrosine, or cysteine ester 
bonds had no effect on motility. The concentrations of the 
various  trypsin-like  protease  substrates  (A-F)  that  were 
needed to inhibit motility were very similar for the four species 
investigated. However, there was an exception since the BLT 
concentration required to block human sperm motility (230 
uM) was 10-fold that needed to inhibit the mobility of rabbit, 
rat, and bull spermatozoa (22-25 uM). 
While the inhibitory concentration of the various substrates 
(chromogenic substrates with nitroanilide, substrates B-E of 
Table III) was being tested,  it was noted that the  medium 
yellowed with time and that this phenomenon was associated 
with the reappearance of sperm motility. The inhibitory effect 
of nonchromogenic substrates like BLT could also be reversed 
with time. The phenomenon of substrate hydrolysis and reap- 
pearance of motility was constantly observed with rat sper- 
matozoa (length of reactivation is 3-4 h) but was less often 
noted with other species as their reactivation durations (be- 
tween 10 and 20 min) were probably too short compared with 
the time required to hydrolyze protease substrates. The fact 
that motility was restored once the substrate was hydrolyzed 
by demembranated spermatozoa suggested the importance of 
Table II. Concentrations of  Protease Inhibitors That Can Prevent the Initiation of  Motility of  Demembranated Spermatozoa* 
Inhibitory concentrations  (uM) 
Protease inhibitors  Rabbit  Rat  Bull  Human 
Group A 
STI  >>50  >>50  >>50  3.7 
LBTI  >>65  >>65  >>65 
Aprotinin  0.5  1.5  0.9  2.8 
Group B 
Leupeptin  98  >> 1,300  >>200  12 
Antipapain  >>650  >>650  >>650 
Boc-gln-leu-lys-H  5  25  8 
D-phe-pro-arg-H  138  120  196 
Group C 
TPCK  >> 1,300 
TLCK  >>1,300 
PPACK  ~  >> 1,300 
Group D 
Zincov inhibitor  ~  >> 1,300 
Benzamidin  >>28,000 
DFP  >>90,000 
380  1,660 
>>23,000  >> 10,000 
* Protease inhibitors were added to the demembmnationmedium at the given concentrations,  and after a  15-s contact with spermatozoa, 0.5 mM Mg. ATP was 
added. Values are mean of at least three different experiments. The symbol >> indicates that the concentration  tested had no inhibitory action on sperm motility 
and that no inhibitory action could be expected near this level. 
D-phe-pro-arg chloromethyl ketone. 
i 2-(N-hydroxycarboxamido)-4-methylpentanoyl-arg-gly amide. 
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Inhibitory concentrations  (vM) 
Protease substrates  Rabbit  Rat  Bull  Human 
A  N-a-benzoyl-carbonyl-lys-thiobenzyl ester (BLT) 
B  Benzoyl-phe-val-arg-p-nitroanilide 
C  Tosyl-gly-pro-arg-p-nitroanilide (Chromozym TH) 
D  Carbobenzoxy-val-gly-arg-p-nitroanilide (Chromozym TRY) 
E  N-benzoyl-DL-arg-p-nitroanilide (BAPNA) 
F  N-a-benzoyl-arg-ethylester (BAEE) 
G  Succinyl-phe-p-nitroanilide 
H  N-benzoyl-tyr-p-nitroanilide 
I  S-benzoyl-cys-p-nitroanilide 
22  25 
73  58 
278  312 
278  335 
377  472 
7,300  9,000 
>>2,600  >>2,600 
>>1,720  >>1,700 
>>1,750  >>1,600 
23  228 
69  107 
286  332 
278  400 
422  520 
9,300  7,800 
* Spermatozoa  were  demembranated  and  reactivated  with  0.5  mM  Mg.ATP.  The  concentration  of protease  substrates  needed  to  block  completely  and 
instantaneously  the motility was then determined.  Values are mean for at least three different experiments. The symbol >> indicates that the concentration  tested 
had no inhibitory action on sperm motility and that no inhibitory action could be expected near this level. 
Table IV. Effect of Hydrolysis on the Capacity of Serine 
Protease Substrates to Inhibit the Motility of  Rat 
Reactivated Spermatozoa 
Table II. Inhibitory Concentrations of Protease Substrates as 
a Function of the Mg.ATP Concentration Used for 
Reactivation of Spermatozoa* 
Conditions  Motility rating*  Inhibitory 
Substrates  Mg. ATP  concentrations 
Control  +++ 
Substrates at 2 ICt0o  t  0  mM  I~M 
BLT  0.5  24  2 min  +++ 
Substrates at 2 IC~0o + trypsin  , + STI  ~  2.5  30 
Substrates at 2 IC~oo  + (STI + trypsin) u  0  5.0  35 
STI + trypsin ~  +++ 
* Motility was quantified  visually on a 0 to ++++ scale: 0, no motility,  +, 
<25% motility, ++, 25-50% motility, +++, 50 to 75% motility, ++++, >75% 
motility. 
t Substrates  were used at twice the  concentration  needed to inhibit  motility 
(ICt0o, concentration  that will inhibit  100% of sperm) (Table III). Substrates 
tested were BLT, Chromozym TH, Chromozym TRY, benzoyl-phe-val-arg-p- 
nitroanilide, and BAPNA. 
A trypsin concentration  that can completely h3~drolyze the various substrates 
within 2 min was selected. After hydrolysis, a threefold excess of STl was added 
to complex and inhibit trypsin molecules. 
I STI  and  trypsin,  at  the  maximal  concentrations  used  above,  were  mixed 
before their  addition  to each substrate.  Under these conditions,  protease sub- 
strates were not hydrolyzed. 
STI and trypsin, at the maximal concentrations  used above, were mixed before 
their addition  to demembranated  reactivated spermatozoa. 
an intact ester bond in the mode of action of these motility 
inhibitors.  It also emphasized the fact that the motile appa- 
ratus (the axoneme) of spermatozoa had suffered no perma- 
nent damage by these substances. 
The importance of ester bonds in the inhibitory action of 
serine protease substrates was further investigated by adding 
prehydrolyzed substrates  to demembranated  reactivated  rat 
spermatozoa (Table IV). Substrates (Table III, A-E) at twice 
their inhibitory concentrations were hydrolyzed to comple- 
tion by trypsin. A threefold excess of STI was then added to 
complex and inhibit trypsin molecules, and the whole mixture 
was added to reactivated sperm. The five substrates tested lost 
their  inhibitory effects on motility after  hydrolysis. Similar 
results were obtained with bull,  rabbit,  and human sperma- 
tozoa. Controls, (STI +  trypsin), and (STI +  trypsin) added 
to substrates  showed that the  complex STI-trypsin had  no 
effect on reactivated sperm or on protease substrates. There- 
fore, the ester bond appears to be essential for the inhibitory 
action of protease substrates. 
As in  the  case  of aprotinin  (3),  the  inhibitory  effects  of 
BLT,  benzoyl-phe-val-arg-p-nitroanilide,  and  Chromozym 
Chromozym TH  0.5  244 
2.0  476 
5.0  654 
Benzoyl-phe-val-arg-p-nitroanilide  0.5  107 
2.5  123 
5.0  145 
* Spermatozoa  were demembranated  and  reactivated  with  Mg.ATP  at  the 
given concentrations,  and the concentrations  of protease substrates needed to 
completely block motility were determined. 
TH, at the concentrations given in Table III, could be reversed 
and  motility reinitiated  by the  immediate  addition  of high 
Mg.ATP concentrations  (2.5-5  mM  final  concentrations). 
Conversely,  when  rat  spermatozoa  were  reactivated  with 
higher Mg.ATP concentrations,  the concentrations of BLT 
and  Chromozym  TH  needed  to  block  motility  increased 
(Table V). Similar results were obtained with bull and human 
spermatozoa. The influence of Mg.ATP, thus motility, was 
once more emphasized by results showing that the amount of 
protease substrates needed to prevent the reactivation was 2- 
3-fold lower than the amount needed to block the movement 
of already reactivated spermatozoa (data not shown). 
Effects of Protease Substrates on the Motility of 
Intact Spermatozoa 
The effects of serine protease substrates were also tested on 
the motility of intact spermatozoa (Table VI). A 2-rain period 
of contact was conceded before  observation  to allow these 
substances to permeate the sperm  membrane.  With the ex- 
ception  of rabbit  sperm,  BLT  could  block  the  motility  of 
intact spermatozoa at a concentration similar to that required 
to inhibit motility in demembranated sperm models. Other 
serine protease substrates were also effective in interrupting 
intact  sperm  motility  though  at  a  concentration  2-6-fold 
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Inhibitory concentrations (#M) 
Protease substrates  Rabbit  Rat  Bull  Human 
N-a-benzoyl-carbonyl-lys-thiobenzyl ester (BLT) 
Tosyl-gly-pro-arg-p-nitroanilide (Chromozym TH) 
Carbobenzoxy-gly-pro-arg-p-nitroanilide (Chromozym TRY) 
N-benzoyl-DL-arg-p-nitroanilide (BAPNA) 
N-a-benzoyl-L-arg-ethylester 
1,370  31  31  487 
1,980  1,670  1,670  566 
1,650  1,670  >>3,100  740 
1,760  734 
>>17,600  >>16,700  >>2,840 
* Protease substrates were added to motile intact sperm suspended in HBS +  BSA or Gey's +  BSA medium and the minimal amount needed to block  motility 
within 2 min was determined. >>, the concentration tested had no inhibitory action on sperm motility, and no inhibitory action could be expected  near this level. 
higher than that needed to stop motility of demembranated 
reactivated spermatozoa (Table III). However, similar to de- 
membranated models, prior hydrolysis of protease substrates 
resulted in the loss of capacity to inhibit intact sperm motility 
(data not shown). 
Discussion 
In this paper, we have shown that a series of protease inhibi- 
tors and protease substrates can affect the motility of sper- 
matozoa. These results raise the possibility that  a  protease 
may be involved in the regulation of sperm motility. 
With the exception of aprotinin, protease inhibitors were 
more effective in  preventing initiation  of motility than  in 
blocking  the  motility  of reactivated  spermatozoa.  For  in- 
stance, boc-gln-leu-lys-H was 4-10-fold more active in pre- 
venting than in stopping motility. Another inhibitor, leupep- 
tin, had no effect on motile spermatozoa but was highly potent 
in preventing the initiation of sperm reactivation. These data 
may suggest either that ATP and protease inhibitors interact 
with a  common receptor molecule or that the binding and 
hydrolysis of ATP affect the affinity of the protease inhibitors 
for its receptor. We have reported a similar phenomenon with 
a factor from the seminal plasma (4). This factor turned out 
to be a dynein ATPase inhibitor (4). However, aprotinin, the 
most potent inhibitor of motility at 40-80-fold the concentra- 
tion needed to block motility, has only marginal effect (25% 
decrease) on dynein ATPase (8). 
Even  though  either  lys  or  arg  residues  were  constantly 
present in the structure of protease inhibitors that could block 
motility at significantly low concentrations, others that pos- 
sessed  the  same amino acids  were inactive.  Aprotinin,  the 
most potent inhibitor, has one lys and two arg at its active 
site. Two of the small peptides with terminal arginal or lysinal 
residues blocked motility, whereas antipapain with a terminal 
arginal and others such as D-phe-leu-lys-H, boc-D-phe-leu-lys- 
H, and boc-D-phe-phe-lys-H (data not shown) had no inhibi- 
tory effect at concentrations up to 1.3 mM. 
DFP, a known irreversible serine protease inhibitor, had no 
effect on the motility of demembranated spermatozoa. This 
inhibitor normally acts by forming a covalent bond with the 
active site of protease (16).  Thus, the lack of effect observed 
could be due to the time required for this chemical reaction. 
The  shortening  of the  reactivation time  observed with  rat 
spermatozoa incubated in the presence of DFP from 2-3 h to 
15 min is consistent with this hypothesis. 
In addition to protease inhibitors, serine protease substrates 
with arg or lys residues could also block sperm motility (Table 
III), thus suggesting that a sperm-associated protease preferred 
the exogenously added substrates to its endogenous substrates. 
This  concept was  supported by results which  showed that 
once the exogenously added  substrates were hydrolyzed by 
the demembranated sperm preparation,  motility reinitiated 
and that trypsin-hydrolyzed substrates had no effect on mo- 
tility (Table IV). The  reversibility of the  motility blockade 
observed in the above experiments further indicated that no 
permanent damage was done to the sperm motility apparatus 
when protease substrates were added. By contrast to protease 
substrates with basic amino acid ester bonds, substrates with 
tyr, phe,  and cys ester bonds  had  no effect on  motility at 
concentrations up to 2 mM (Table III). These results empha- 
sized the specificity of the sperm-associated protease. 
Within the four species tested, the concentrations of pro- 
tease substrates needed to block sperm motility were similar. 
However, there was an exception to this phenomenon. BLT, 
the  most potent  substrate,  inhibited  motility of rabbit,  rat, 
and bull spermatozoa at concentrations ranging between 22 
and 25 uM, whereas a concentration of 230 uM was required 
to stop human spermatozoa. This peculiarity of human sper- 
matozoa was first thought to be caused by the presence of 
Percoll (colloidal silica particles coated with polyvinylpyroli- 
done)  present in  the  medium used to isolate spermatozoa. 
This possibility was rejected since human spermatozoa, sim- 
ply washed in HBS +  BSA buffer and then reactivated, had 
their motility blocked by 210 uM BLT. It was neither due to 
the presence of extra spermatozoal proteases, as human sper- 
matozoa  washed  through  Percoll  gradients  are  essentially 
devoid of other cellular elements and  debris so  frequently 
found in human semen. 
As in the case of aprotinin (3), the concentrations of pro- 
tease substrates needed to block the motility of demembra- 
nated spermatozoa varied according to the concentration of 
Mg. ATP used for reactivation (Table V).  In addition,  once 
motility was initiated by Mg.ATP (0.5 mM) and then blocked 
by protease substrates (Table III), motility could be reinitiated 
by the rapid addition  of more Mg.ATP (2.5-5  mM).  Fur- 
thermore,  spermatozoa appear to be more sensitive to the 
effects of protease substrates in the absence of Mg. ATP; the 
concentration  of substrates  needed  to  prevent reactivation 
was two- to threefold lower than that  needed to block the 
motility of already reactivated spermatozoa (data not shown). 
The possibility that protease substrates would act as dynein 
ATPase inhibitors was rejected since BLT did not inhibit bull 
dynein ATPase, even at a concentration of 480 #M (unpub- 
lished  results).  Nevertheless the  results may suggest  that  a 
sperm-specific protease, Mg-ATP, and dynein ATPase have 
some interactions. 
When reactivated, rat spermatozoa were inhibited by  1.5 
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lasting for 2-2.5 h. This observation raised the possibility that 
aprotinin would block motility acting as a  substrate for the 
motility-related protease. It is known that the lys~5-ala  t6 bond 
present at the active site of aprotinin is subject to hydrolysis 
by  catalytic  amounts of proteases and that  this  hydrolyzed 
bond is also subject to thermodynamically controlled resyn- 
thesis (20).  If a trypsin-like protease, such as starfish trypsin 
1, very rapidly and with high specificity, hydrolyzes the lys  ~5- 
arg j6 bond and, at the same time, dissociates from aprotinin 
quickly, resynthesis is prevented and hydrolyzed aprotinin is 
found  in  the  medium  (7).  It  is  possible  that  the  protease 
involved in sperm  motility has these properties and uses to 
some extent aprotinin as a substrate. We have observed, with 
reactivated human and  rabbit spermatozoa, that the inhibi- 
tion caused by aprotinin could be reversed by further addition 
of DTT (concentration in the reactivation medium increased 
to 2.5  mM) (unpublished results). Furthermore, when apro- 
tinin  was  incubated  with  2.5  mM  DTT  for  1  h  at  room 
temperature, the amount of aprotinin needed to block motil- 
ity of human reactivated spermatozoa doubled.  DTT  alone 
did not affect the reactivation. These data would also support 
the  hypothesis  that  aprotinin  is  substrate  for  the  motility- 
related protease since DTT  can  reduce disulfide  bonds and 
since  once the cys~4-cys 38 disulfide  bond  of aprotinin is  re- 
duced, the rate of hydrolysis of the lys~S-ala  ~6 bond is facili- 
tated (9,  19). 
Results with demembranated reactivated sperm would sug- 
gest that permeable substrates like BLT or Chromozym TH 
block motility of intact spermatozoa via a  mechanism com- 
patible with their mode of action of reactivated sperm, that is 
by inhibiting a sperm-associated specific serine protease. 
In conclusion, the inhibitory effects of protease inhibitors 
and substrates on sperm motility strongly suggest that a serine 
protease with lys and arg ester bond specificity is involved in 
the control of sperm motility. This may imply that sperma- 
tozoa must have a  second enzyme to repair the ester bond 
hydrolyzed by the protease.  Alternatively, the same protein 
structure could carry both enzymatic functions, hydrolyzing 
and  repairing the same bond.  The localization of these two 
enzymatic activities, as well as the nature of the endogenous 
substrates involved,  remain to be  established.  The  fact that 
protease substrates also block motility of intact spermatozoa 
from four mammalian species further emphasizes the physi- 
ological relevance of this new regulatory system. 
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